About Aclaris (ACRS)
Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a physician-led, biopharmaceutical company focused on immuno-inflammatory diseases. The Company is focused on leveraging its experience in drug discovery and development and kinase inhibit... Read more
- USD6.85
- USD6.92
- USD6.58
- USD18.96
- -9.70%
- 31M
- 867.42k
- 1.05M
- 471M
- 5.77
- -53.80%
Stock News
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
